Glucocorticoids in the treatment of rheumatic diseases - An update on the mechanisms of action

被引：255
|
作者：
Buttgereit, F
Straub, RH
Wehling, M
Burmester, GR
机构：
[1] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
[2] Univ Hosp, Regensburg, Germany
[3] Heidelberg Univ, Mannheim Hosp, Heidelberg, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 11期
关键词：
D O I：
10.1002/art.20583
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3408 / 3417
页数：10
相关论文
共 50 条
  • [41] The safety of low-dose glucocorticoids in rheumatic diseases
    Hwang, Y. G.
    Saag, K.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (05) : S104 - S112
  • [42] Glucocorticoids in Patients with Rheumatic Diseases: Friends or Enemies of Bone?
    Ciccarelli, Fedra
    De Martinis, Massimo
    Ginaldi, Lia
    [J]. CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 596 - 603
  • [43] Update on rheumatic manifestations of infectious diseases
    Becker, Jennifer
    Winthrop, Kevin L.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (01) : 72 - 77
  • [44] The Art and Science of Tapering Glucocorticoids in Patients with Rheumatic Diseases
    Mofrad, Alireza
    Rajbhandary, Rosy
    Panush, Richard S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1252 - 1252
  • [45] Inflammatory mechanisms and rheumatic diseases
    Wichert, P
    [J]. INTERNIST, 1999, 40 (09): : 913 - 913
  • [46] Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis
    Grzanka, Alicja
    Misiolek, Maciej
    Golusinski, Wojciech
    Jarzab, Jerzy
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2011, 268 (02) : 247 - 253
  • [47] Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis
    Alicja Grzanka
    Maciej Misiołek
    Wojciech Golusiński
    Jerzy Jarząb
    [J]. European Archives of Oto-Rhino-Laryngology, 2011, 268 : 247 - 253
  • [48] Balneotherapy year in review 2021: focus on the mechanisms of action of balneotherapy in rheumatic diseases
    Sara Cheleschi
    Sara Tenti
    Iole Seccafico
    Isabel Gálvez
    Antonella Fioravanti
    Eduardo Ortega
    [J]. Environmental Science and Pollution Research, 2022, 29 : 8054 - 8073
  • [49] Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action
    Bayry, Jagadeesh
    Lacroix-Desmazes, Sebastien
    Kazatchkine, Michel D.
    Kaveri, Srini V.
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (05): : 262 - 272
  • [50] Balneotherapy year in review 2021: focus on the mechanisms of action of balneotherapy in rheumatic diseases
    Cheleschi, Sara
    Tenti, Sara
    Seccafico, Iole
    Galvez, Isabel
    Fioravanti, Antonella
    Ortega, Eduardo
    [J]. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2022, 29 (06) : 8054 - 8073
12345